Q2 2026 13F · SEC CIK 2092853

Odyssean, LLC

Asset managerFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value: $614.9M
Reported positions: 485
Holdings vs S&P 500, 3 yrs: —
Assets under management: $373.3M

Odyssean, LLC is an asset manager that reported 485 positions worth $614.9M in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Ultragenyx Pharmaceutical in (RARE, 0.7%), Kymera Therapeutics Inc (KYMR, 0.6%), Ideaya Biosciences Inc (IDYA, 0.6%).

Odyssean, LLC holdings largest 50 of 485 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Odyssean, LLC 13F holdings
Stock	% of 13F value	Q1 2026	Shares	Share change	Reported value
RAREUltragenyx Pharmaceutical in	0.7%	0.5%	122,087	+81.1%	$4.1M
KYMRKymera Therapeutics Inc	0.6%	—	34,485	—	$4.0M
IDYAIdeaya Biosciences Inc	0.6%	—	102,582	—	$3.8M
PCVXVaxcyte Inc	0.6%	—	62,638	—	$3.6M
AFRMAffirm Hldgs Inc	0.6%	—	43,968	—	$3.6M
CLDXCelldex Therapeutics Inc New	0.6%	—	95,069	—	$3.5M
LOARLoar Holdings Inc	0.6%	—	43,660	—	$3.5M
MIRMMirum Pharmaceuticals Inc	0.6%	—	29,924	—	$3.5M
DASHDoordash Inc	0.6%	—	18,915	—	$3.5M
KRYSKrystal Biotech Inc	0.6%	—	9,349	—	$3.5M
VIKViking Hldgs Ltd	0.5%	0.6%	32,226	+55.3%	$3.4M
MEDPMedpace Hldgs Inc	0.5%	—	6,361	—	$3.4M
TOSTToast Inc	0.5%	—	119,775	—	$3.3M
AHRAmerican Healthcare REIT Inc	0.5%	—	63,508	—	$3.3M
NICNicolet Bankshares Inc	0.5%	0.5%	20,012	+101.0%	$3.3M
VEEVVeeva Sys Inc	0.5%	—	18,634	—	$3.3M
GRBKGreen Brick Partners Inc	0.5%	—	41,180	—	$3.3M
ESNTEssent Group Ltd Com	0.5%	0.5%	50,922	+102.4%	$3.3M
MSGEMadison Square Garden Entmt	0.5%	0.5%	40,452	+60.2%	$3.3M
IPARInterparfums Inc	0.5%	0.5%	29,208	+87.0%	$3.3M
EEFTEuronet Worldwide Inc	0.5%	—	44,597	—	$3.3M
NUNu Hldgs Ltd	0.5%	—	243,873	—	$3.3M
SQBlock Inc	0.5%	—	42,762	—	$3.2M
HCIHci Group Inc	0.5%	—	18,528	—	$3.2M
DELLDell Technologies Inc	0.5%	0.5%	7,515	-15.3%	$3.2M
KGSKodiak Gas Svcs Inc	0.5%	0.5%	43,034	+67.8%	$3.2M
RDNTRadnet Inc	0.5%	—	52,421	—	$3.2M
PPLIPeople Inc	0.5%	0.6%	69,719	+80.4%	$3.2M
DNLIDenali Therapeutics Inc Com	0.5%	—	125,062	—	$3.2M
ABNBAirbnb Inc	0.5%	0.5%	22,474	+103.9%	$3.2M
AMRXAmneal Pharmaceuticals Inc	0.5%	0.5%	183,507	+62.5%	$3.2M
CRNXCrinetics Pharmaceuticals in	0.5%	—	84,456	—	$3.2M
YELPYelp Inc	0.5%	—	128,693	—	$3.2M
KNSLKinsale Cap Group Inc	0.5%	—	9,547	—	$3.1M
CHEFChefs Whse Inc	0.5%	0.5%	32,758	+38.3%	$3.1M
AEPAmerican Elec Pwr Co Inc	0.5%	0.5%	23,004	+109.2%	$3.1M
CAKECheesecake Factory Inc	0.5%	—	39,490	—	$3.1M
SFBSServisfirst Bancshares Inc	0.5%	—	36,082	—	$3.1M
NTCTNetScout Systems, Inc.	0.5%	0.6%	71,772	+44.1%	$3.1M
BOXBox Inc	0.5%	—	117,086	—	$3.1M
MSGKMadison Square Grdn Sprt Corp Cl A	0.5%	0.6%	7,728	+64.4%	$3.1M
AWKAmerican Wtr Wks Co Inc New Com	0.5%	0.6%	23,536	+111.6%	$3.1M
ABRArbor Realty Trust Inc.	0.5%	—	570,598	—	$3.1M
TSLATesla Inc	0.5%	—	7,314	—	$3.1M
AVPTAvepoint Inc	0.5%	—	273,488	—	$3.1M
BBIOBridgebio Pharma Inc	0.5%	—	41,015	—	$3.1M
VNOVornado Rlty Tr	0.5%	—	77,680	—	$3.1M
NXSTNexstar Media Group Inc	0.5%	—	17,036	—	$3.0M
VVisa Inc	0.5%	—	8,866	—	$3.0M
BRK-BBerkshire Hathaway Inc Del	0.5%	0.5%	6,076	+103.1%	$3.0M

What Odyssean, LLC bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year: —
3 years: —
5 years: —

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter	13F value	Positions
Q2 2026	$614.9M	485
Q1 2026	$273.9M	418
Q4 2025	$139.2M	254

Questions about Odyssean, LLC's portfolio

What stocks does Odyssean, LLC own?

Odyssean, LLC's latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 485 positions worth $614.9M. The largest are Ultragenyx Pharmaceutical in (RARE) at 0.7%, Kymera Therapeutics Inc (KYMR) at 0.6%, Ideaya Biosciences Inc (IDYA) at 0.6%, Vaxcyte Inc (PCVX) at 0.6% and Affirm Hldgs Inc (AFRM) at 0.6%.

What did Odyssean, LLC buy last quarter?

In Q2 2026, Odyssean, LLC added American Wtr Wks Co Inc New Com (AWK) (+111.6% shares), American Elec Pwr Co Inc (AEP) (+109.2% shares) and Airbnb Inc (ABNB) (+103.9% shares), compared with its Q1 2026 filing.

What did Odyssean, LLC sell last quarter?

In Q2 2026, Odyssean, LLC cut from its top 50 United Therapeutics Corp Del (UTHR), cut from its top 50 Lyondellbasell Industries NV (LYB), cut from its top 50 Matador Resources Co. (MTDR), cut from its top 50 Permian Resources Corp (PR), cut from its top 50 Freedom Holding Corp (FRHC) and Dell Technologies Inc (DELL) (-15.3% shares), compared with its Q1 2026 filing.

When is Odyssean, LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. Odyssean, LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Odyssean, LLC manage?

Odyssean, LLC reported $373.3M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $614.9M.